These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 6187194

  • 1. [Investigation of interferon system in Vogt-Koyanagi-Harada disease].
    Ohno S, Kotake S, Fjuii N, Minagawa T.
    Nippon Ganka Gakkai Zasshi; 1982; 86(10):1574-80. PubMed ID: 6187194
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
    Maezawa N, Tsukahara S.
    Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
    [No Abstract] [Full Text] [Related]

  • 5. [Surface marker studies on the activated peripheral blood lymphocytes of Vogt-Koyanagi-Harada's disease].
    Okubo K, Kurimoto S, Okubo K, Yokoyama MM.
    Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):358-63. PubMed ID: 3873787
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cellular hypersensitivity to uveal pigment confirmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.
    Hammer H.
    Br J Ophthalmol; 1974 Sep; 58(9):773-6. PubMed ID: 4473998
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Lymphocyte transformation test and migration inhibition test of macrophages in Vogt-Koyanagi-Hirada's syndrome (author's transl)].
    Yuasa T, Murai Y, Hoki T, Mimura Y.
    Nippon Ganka Gakkai Zasshi; 1973 Oct; 77(10):1652-7. PubMed ID: 4799026
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Investigation of interferon in the sera and cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease (author's transl)].
    Kato F, Ohno S, Matsuda H, Fujii N, Minagawa T.
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):217-21. PubMed ID: 6168187
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease.
    Okubo K, Kurimoto S, Okubo K, Matsumoto K, Yokoyama MM.
    J Clin Lab Immunol; 1985 May; 17(1):49-52. PubMed ID: 3840207
    [Abstract] [Full Text] [Related]

  • 18. HLA-D antigen of Japanese origin (LD-Wa) and its association with Vogt-Koyanagi-Harada syndrome.
    Yakura H, Wakisaka A, Aizawa M, Itakura K, Tagawa Y.
    Tissue Antigens; 1976 Jul; 8(1):35-42. PubMed ID: 60795
    [Abstract] [Full Text] [Related]

  • 19. [The effect of corticosteroids on interferon system in Vogt-Koyanagi-Harada's disease].
    Kotake S, Ohno S, Fujii N, Minagawa T.
    Nippon Ganka Gakkai Zasshi; 1984 Jul; 88(7):1021-6. PubMed ID: 6208768
    [No Abstract] [Full Text] [Related]

  • 20. Vogt-Koyanagi-Harada syndrome.
    el-Gammal Y, el-Aguizy H.
    Bull Ophthalmol Soc Egypt; 1970 Jul; 63(67):325-8. PubMed ID: 5520193
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.